AGIO
NASDAQ
$40.06
Agios Pharmaceuticals Inc (AGIO)
Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $42.62 (+6.39%)
Market Cap
$2.37B
P/B Ratio
0.99
Free Cash Flow Yield
-16.26%
Beta (5Y)
1.02
Price Chart
Valuation
Market Cap$2.37B
Forward P/E2.47
P/S35.95
P/B0.99
Profitability
Total Revenue (TTM)$66M
Gross Profit (TTM)-$288M
EBITDA-$477M
Operating Margin-530%
EPS-$7.22
Financial Health
Free Cash Flow Yield-16.26%
Growth & Risk
FCF 5Y CAGR+3.96%
Beta (5Y)1.02
Sharpe Ratio0.42